Literature DB >> 24450637

Structure-function relationships and supramolecular organization of the EGFR (epidermal growth factor receptor) on the cell surface.

Sarah R Needham1, Laura C Zanetti-Domingues1, Michael Hirsch1, Daniel J Rolfe1, Christopher J Tynan1, Selene K Roberts1, Marisa L Martin-Fernandez1, David T Clarke1.   

Abstract

Dimerization and higher-order oligomerization are believed to play an important role in the activation of the EGFR (epidermal growth factor receptor). Understanding of the process has been limited by the lack of availability of suitable methods for the measurement in cells of distances in the range 10-100 nm, too short for imaging methods and too long for spectroscopic methods such as FRET. In the present article, we review the current state of our knowledge of EGFR oligomerization, and describe results from a new single-molecule localization method that has allowed the quantitative characterization of the distribution of EGFR-EGFR distances in cells. Recent data suggest the involvement of cortical actin in regulating the formation of EGFR complexes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24450637     DOI: 10.1042/BST20130236

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  8 in total

Review 1.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

2.  Linear Chains of HER2 Receptors Found in the Plasma Membrane Using Liquid-Phase Electron Microscopy.

Authors:  Kelly Parker; Patrick Trampert; Verena Tinnemann; Diana Peckys; Tim Dahmen; Niels de Jonge
Journal:  Biophys J       Date:  2018-06-18       Impact factor: 4.033

3.  Subdomain 2, Not the Transmembrane Domain, Determines the Dimerization Partner of Growth Hormone Receptor and Prolactin Receptor.

Authors:  Ying Liu; Jing Jiang; Bradford Lepik; Yue Zhang; Kurt R Zinn; Stuart J Frank
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  Palbociclib augments Neratinib killing of tumor cells that is further enhanced by HDAC inhibition.

Authors:  Laurence Booth; Jane L Roberts; Rumeesa Rais; Richard E Cutler; Irmina Diala; Alshad S Lalani; Andrew Poklepovic; Paul Dent
Journal:  Cancer Biol Ther       Date:  2018-09-05       Impact factor: 4.742

5.  Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization.

Authors:  Ursula D Ramirez; Anna S Nikonova; Hanqing Liu; Anna Pecherskaya; Sarah H Lawrence; Ilya G Serebriiskii; Yan Zhou; Matthew K Robinson; Margret B Einarson; Erica A Golemis; Eileen K Jaffe
Journal:  BMC Cancer       Date:  2015-05-28       Impact factor: 4.430

6.  Correlative Fluorescence- and Electron Microscopy of Whole Breast Cancer Cells Reveals Different Distribution of ErbB2 Dependent on Underlying Actin.

Authors:  Indra Navina Dahmke; Patrick Trampert; Florian Weinberg; Zahra Mostajeran; Franziska Lautenschläger; Niels de Jonge
Journal:  Front Cell Dev Biol       Date:  2020-06-30

7.  Enhanced dimerization drives ligand-independent activity of mutant epidermal growth factor receptor in lung cancer.

Authors:  Christopher C Valley; Donna J Arndt-Jovin; Narain Karedla; Mara P Steinkamp; Alexey I Chizhik; William S Hlavacek; Bridget S Wilson; Keith A Lidke; Diane S Lidke
Journal:  Mol Biol Cell       Date:  2015-09-02       Impact factor: 4.138

8.  Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.

Authors:  Sindhu Nair; Hoa Q Trummell; Rajani Rajbhandari; Nanda K Thudi; Susan E Nozell; Jason M Warram; Christopher D Willey; Eddy S Yang; William J Placzek; James A Bonner; Markus Bredel
Journal:  PLoS One       Date:  2020-02-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.